Search Results - "Snir, Jonatan A."

White matter integrity is associated with gait impairment and falls in mild cognitive impairment. Results from the gait and brain study by Snir, Jonatan A., Bartha, Robert, Montero-Odasso, Manuel

“…Mild Cognitive Impairment (MCI) is an intermediate state between normal cognition and dementia that is associated with twice the risk of falls. It is unknown…”
Get full text

In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain by Heyn, Chris, Ronald, John A., Ramadan, Soha S., Snir, Jonatan A., Barry, Andrea M., MacKenzie, Lisa T., Mikulis, David J., Palmieri, Diane, Bronder, Julie L., Steeg, Patricia S., Yoneda, Toshiyuki, MacDonald, Ian C., Chambers, Ann F., Rutt, Brian K., Foster, Paula J.

“…Metastasis (the spread of cancer from a primary tumor to secondary organs) is responsible for most cancer deaths. The ability to follow the fate of a…”
Get full text

Cellular Magnetic Resonance Imaging: In Vivo Imaging of Melanoma Cells in Lymph Nodes of Mice by Foster, Paula J, Dunn, Elizabeth A, Karl, Kristina E, Snir, Jonatan A, Nycz, Colleen M, Harvey, Alfred J, Pettis, Ron J

“…Metastasis is responsible for most deaths due to malignant melanoma. The clinical significance of micrometastases in the lymph is a hotly debated topic, but an…”
Get full text

ASYMMETRICALLY LOW WHITE MATTER INTEGRITY IN SENIORS WITH MCI AND POOR GAIT by Snir, Jonatan A, Bartha, Robert, MonteroOdasso, Manuel

Get full text

An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model by Snir, Jonatan A, Suchy, Mojmir, Bindseil, Geron A, Kovacs, Michael, Chronik, Blaine A, Hudson, Robert H E, Pasternak, Stephen H, Bartha, Robert

“…Early detection of Alzheimer's disease (AD) pathology is a serious challenge for both diagnosis and clinical trials. The aspartyl protease, Cathepsin D (CatD),…”
Get more information

Surface dose measurement for helical tomotherapy by Snir, Jonatan A., Mosalaei, Homeira, Jordan, Kevin, Yartsev, Slav

“…Purpose: To compare the surface dose measurements made by different dosimeters for the helical tomotherapy (HT) plan in the case of the target close to the…”
Get full text

Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease by Snir, Jonatan A, Suchy, Mojmir, Lawrence, Keith St, Hudson, Robert H E, Pasternak, Stephen H, Bartha, Robert

“…Cathepsin D (CatD) is a lysosomal protease that is elevated early in Alzheimer's disease (AD). We have previously developed a Targeted contrast agent (CA) to…”
Get more information

Comment on “Monte Carlo evaluations of the absorbed dose and quality dependence of Al2O3 in radiotherapy photon beams” [Med. Phys. 36, 4421–4424 (2009)] by Snir, Jonatan A., Van Dyk, Jake, Yartsev, Slav

Get full text

A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer’s disease mouse model by Snir, Jonatan A, Suchy, Mojmir, Bindseil, Geron A, Chronik, Blaine A, Hudson, Robert H.E, Pasternak, Stephen H, Bartha, Robert

Get full text

A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer’s disease mouse model by Snir, Jonatan A, Suchy, Mojmir, Bindseil, Geron A, Chronik, Blaine A, Hudson, Robert H.E, Pasternak, Stephen H, Bartha, Robert

Get full text

P3‐239: Asymmetrically Low White Matter Integrity in Seniors with Mci and POOR GAIT by Snir, Jonatan A., Bartha, Robert, MonteroOdasso, Manuel

Get full text

Surface dose measurement for helical tomotherapy: Skin dosimetry for tomotherapy by Snir, Jonatan A., Mosalaei, Homeira, Jordan, Kevin, Yartsev, Slav

Get full text

IC‐P‐024: A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer's disease mouse model by Snir, Jonatan A., Suchy, Mojmir, Bindseil, Geron A., Chronik, Blaine A., Hudson, Robert H.E., Pasternak, Stephen H., Bartha, Robert

Get full text

O1‐02‐05: A novel positron emission tomography contrast agent targeting cathepsin d shows preferential in vivo retention in an Alzheimer's disease mouse model by Snir, Jonatan A., Suchy, Mojmir, Bindseil, Geron A., Chronik, Blaine A., Hudson, Robert H.E., Pasternak, Stephen H., Bartha, Robert

Get full text

Comment on “Monte Carlo evaluations of the absorbed dose and quality dependence of in radiotherapy photon beams” [Med. Phys. 36, 4421–4424 (2009)] by Snir, Jonatan A., Van Dyk, Jake, Yartsev, Slav

Get full text

Comment on “Monte Carlo evaluations of the absorbed dose and quality dependence of Al 2 O 3 in radiotherapy photon beams” [ Med. Phys. 36, 4421–4424 (2009)] by Snir, Jonatan A., Van Dyk, Jake, Yartsev, Slav

Get full text

Cellular Magnetic Resonance Imaging: In Vivo Imaging of Melanoma Cells in Lymph Nodes of Mice1 by Foster, Paula J, Dunn, Elizabeth A, Karl, Kristina E, Snir, Jonatan A, Nycz, Colleen M, Harvey, Alfred J, Pettis, Ron J

“…Metastasis is responsible for most deaths due to malignant melanoma. The clinical significance of micrometastases in the lymph is a hotly debated topic, but an…”
Get full text